1) A. Luger, B. Watschinger, P. Deuster, T. Svoboda, M. Clodi, G.P. Chrousus: Plasma Growth Hormon and Prolactin responses to graded levels of acute exercise and lactate infusion. Neuroendocrinology 1992;56:112-117 [165 KB]

2) T. Svoboda, A. Wagner, P. Speiser, M. Clodi, A. Luger: Epidermal Growth Factor plasma concentrations in healthy control persons, acute and chronic stress and during pregnancy. Horm Metab Res. 1992;24:582-584. [161 KB]

3) M. Clodi, T. Svoboda, H. Kotzmann, R. Deyssig, W. Woloszczuk, CC. Zielinski, A. Luger: Effect of elevated serum prolactin concentrations on cytokine production and natural killer cell activity. Neuroendocrinology 1992;56:775-779. [166 KB]

4) H. Gisslinger, T. Svoboda, M. Clodi, B. Gilly, H. Ludwig, R. Hawelec, A. Luger: Interferon alpha stimulates the Hypothalamic-Pituitary-Adrenal-Axis in vivo and in vitro. Neuroendocrinology 1993;57:489-495. [357 KB]

5) B. Ludvik, M. Clodi, A. Kautzky-Willer, M. Capek, E. Hartter, G. Pacini, R. Prager: Effects of dexamethasone on insulin sensivity, islet amyloid polypeptide and insulin secretion in humans. Diabetolgia 1993;36:84-87. [603 KB]

6) T. Svoboda, H. Kotzmann, M. Clodi, P. Bernecker, G. Geyer, A. Luger: The non ergot D2-dopamine agonist CV 205-502 decreases growth hormone concentrations in acromegalic patients. Endocr Res 1994;20:59-63. [2.316 KB]

7) W. Pirker, T. Brücke, M. Riedl, M. Clodi, A. Luger, S. Asenbaum, I. Podrecka and L. Deecke: Iodine-123-IBZM-SPECT:studies in 15 patients with pituitary tumors. J Neural Transm [GenSect] 1994;97:235-244. [1.070 KB]

8) A. Kautzky-Willer, K. Thomaseth, G. Pacini, M. Clodi, B. Ludvik, C. Streli, W. Waldhäusl, R. Prager: Role of islet amyloid polypeptide secretion in insulin- resistant humans. Diabetologia 1994;37:188-194. [1.557 KB]

9) B. Ludvik, M. Clodi, A. Kautzky-Willer, M. Schuller, H. Graf, E. Hartter, G. Pacini and R. Prager: Increased levels of circulating Islet Amyloid Polypeptide in patients with chronic renal failure have no effect on insulin scretion. J. Clin. Invest. 1994;94:2045-2050. [1.087 KB]

10) P. Fürnsinn, H. Leuvenink, M. Roden, P. Nowotny, B. Schneider, M. Rohac, T. Pieber, M. Clodi, and W. Waldhäusl: Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am. J. Physiol. 1994;267(Endocrinol.Metab.30):E300-E305 [2.202 KB]

11) H. Kotzmann, T. Svoboda, P. Bernecker, M. Clodi, W. Woloszczuk, B. Niederle, W. Waldhäusl, A. Luger: Dinatriumpamidronat (APD) als Therapie der Hypercalciämie bei primärem Hyperparathyreoidismus. Wien Klin Wochenschr 1994;106:422-425 [535 KB]

12) H. Kotzmann, M. Köller, S. Czernin, M. Clodi, T. Svoboda, M. Riedl, G. Boltz- Nitulescu, CC. Zielinski, A. Luger: Effect of elevated Growth hormone concentrations on the phenotype and functions of human Lymphocytes and natural killer cells. Neuroendocrinology 1994;60:618-625 [2.414 KB]

13) F. Längle, T. Soliman, N. Neuhold, G. Widhalm, B. Niederle, S. Roka, K. Kaserer, W. Blauensteiner, K. Dam, M. Clodi, J. Flores, A. Loidl, B. Schwarzmüller, E. Huber, G. Jahl, K. Wamprechtsberger, R. Roka: CD 15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? World-J-Surg 1994;18:583-587. [3.265 KB]

14) H. Kotzmann, M. Linkesch, B. Ludvik, M. Clodi, A. Luger, G. Schernthaner, R. Prager, R. Klauser. Effect of danazol induced chronic hyperglucagonemia on glucose tolerance and turnover. Eur J Clin Invest 1995;25:942-947 [2.820 KB]

15) M. Clodi, H. Kotzmann, G. Fischer, M. Riedl, O. Presslich, C. Schneider, K. Diamant, A. Luger. Life threatening hemolysis in a 27 year old drug addict. European Psychiatry 1995;10: 416 (letter) [1.203 KB]

16) H. Kotzmann, M. Riedl, M. Clodi, U. Barnas, A. Kaider, P. Höcker, A. Luger. The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. Eur J Clin Invest 1996;12:1175-1181 [726 KB]

17) A. Kautzky-Willer, K. Thomaseth, M. Clodi, B. Ludvik, W. Waldhäusl, R. Prager, G. Pacini: B-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 1996;45:486-491 [3.820 KB]

18) U. Hoffmann, C. Kurek, K. Kostner, C. Scholten, M. Clodi, I. Lang, T. Stefenelli: Atypical elevation of creatinin phosphokinase and isoenzymes (CK-MB) levels in a patient with mitral valve disease. Europ. Heart J. 1996;17:1764-5 (letter) [204 KB]

19) M. Clodi, H. Kotzmann, M. Riedl, A. Schmidt, U. Barnas, F. Mühlbacher, G. Mustafa, W. Hörl, W. Waldhäusl, G. Mayer and A. Luger: The long acting dopamine agonist bromocriptine mesylate as additive immunsuppressive drug after kidney transplantation. Nephrology Dialysis Transplantation 1997; Apr,V12N4:748-752 [149 KB]

20) M. Köller, H. Kotzmann, M. Clodi, M. Riedl, A. Luger. Effect of elevated serum prolactin concentration on the immuno-phenotype of human lymphocytes, mitogen induced proliferation and phagocytic activity of polymorphonuclear cells. Eur J Clin Invest 1997;Aug 27(8):662-666 [301 KB]

21) K. Thomaseth, G. Pacini, M. Clodi, A. Kautzky-Willer, J.J. Nolan, R. Prager, J.M. Olefsky, B. Ludvik. Amylin release during oral glukose tolerance test. Diabetic Medicine 1997;14:S29-S34

22) H. Kotzmann, C. Abela, J. Heindl, M. Clodi, M. Riedl, U. Barnas, K. Geissler, B. Niederle, W. Waldhäusl, A. Luger. Effect of successful parathyroidectomy on hematopoietic progenitor cells and parameters of red blood cells in patients with primary hyperparathyroidism. Horm Metab Res 1997; V29,N8:387-392 [347 KB]

23) M. Clodi, R. Oberbauer, W. Waldhäusl, G. Maurer, G. Kostner, K. Kostner: Urinaryexcretion of apo (a) fragments in NIDDM patients.Diabetologia 1997; 40:1455-1460 [259 KB]

24) H. Kotzmann, M. Riedl, P. Bernecker, M. Clodi, F. Kainberger, A. Kaider,W. Woloszczuk, A. Luger: Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.Calcified Tissue Int 1998; Jan, V62 N1:40-46 [776 KB]

25) M. Clodi, M. Riedl, S. Schmaldienst, A. Vichytil, H. Kotzmann, A. Kaider, G. Mayer, C. Bieglmayer, W. Waldhäusl, A. Luger: Adrenal function in patients with chronic renal failure.Am J Kidney Diseases 1998 Jul, V32 N1:52-55. [48 KB]

26) M. Clodi, K. Thomaseth, G. Pacini, K. Hermann, A. Kautzky-Willer, W. Waldhäusl, R. Prager, B. Ludvik: Distribution and kinetics of amylin in humans.Am J Physiol-Endocrinol and Metab 1998; May, V37 N5:E903-E908. [135 KB]

27) K. Kostner, M. Clodi, B. Watschinger, W. Hörl, K. Derfler, K. Huber: Decreased uirnary apo(a) excretion in patients with impaired renal function. Eur J Clin Invest. 1998; Jun, 28(6): 447-452.

28) H. Kotzmann, M. Koller, C. Abela, M. Clodi, M. Riedl, W. Graninger, B. Niederle,A. Luger: Effects of parathyroid hormone and serum calcium on the phenotypeand function of mononuclear cells in patients with primary hyperparathyroidism.Eur J Clin Invest 1998; May, 28(5): 353-358 [412 KB]

29) M. Clodi, J. Klarlund, P. Vollenweider, N. Nakashima, M. Czech, J. Olefsky: Effectsof GRP1 (General Receptor for Phosphoinositides 1) on Insulin and IGF I induced GLUT 4 Translocation, Membrane Ruffling and DNA Synthesis.Endocrinology 1998; 139:4984-490. [1.319 KB]

30) P. Vollenweider, M. Clodi, S. Martin, T. Imamura, W, Kavanaugh, J. M. Olefsky: An SH2 containing 5'Inositolphosphatase (SHIP) inhibits insulin-induced GLUT4 Translocation and Growth factors induced Actin Filament rearrangement.Molecular and Cellular Biology, 1999, V19 N2:1081-1091. [2.199 KB]

31) M. Clodi, R. Oberbauer R, Bodlaj G, Hofmann J, Maurer G, Kostner K.: Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients. Metabolism. 1999 Mar; 48(3):369-72.

32)T. Imamura, P. Vollenweider, K. Egawa, M. Clodi, K. Ishibashi, N. Nakashima, S. Ugi, J. Adams, J. Brown, J. Olefsky: G Alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytenMolecular and Cellular Biology, 1999, 10 V19:6765-6774. [1.755 KB]

33) Blank D, Riedl M, Reitner A, Schnack C, Schernthaner G, Clodi M, Frisch H, Luger A: Growth hormone replacement therapy is not associated with retinal changes. J Clin Endocrinol Metab 2000 Feb;85(2):634-6 [1.125 KB]

34) Kostner K, Clodi M, Bodlaj G, Hoffmann U, Hermann K, Maurer G, Pacher R, Horl WH: Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males. Wien Klin Wochenschr 2000 Feb 11;112(3):121-5

35) Roden M, Ludwig C, Nowotny P, Schneider B, Clodi M, Vierhapper H, Roden A,Waldhausl W: Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes Relat Metab Disord 2000 Aug;24(8):976-81 [835 KB]

36) M. Riedl, B. Ludvik, G. Pacini, M. Clodi, H. Kotzmann, O. Wagner, A. Kautzky-Willer, R. Prager and A. Luger: The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy Eur J Clin Invest. 2000 Sep;30(9):771-8. [2.703 KB]

37) Riedl M, M. Clodi, Kotzmann H, Hainfellner JA, Schima W, Reitner A, Czech T, Luger : Apoplexy of a pituitary macroadenoma with reversible third, fourth and sixth cranial nerve palsies following administration of hypothalamicEur J Radiol 2000 Oct;36(1):1-4 [1.807 KB]

38) M. ClodiKortikosteroide im septischen SchockWien. Med. Wschr. 2002:152;555-558 [476 KB]

39) M. Riedl, M. ClodiLipide und DiabetesJ Kardiol 2002; 9:317-320 [308 KB]

40) B. Ludvik, K. Thomaseth, J. Nolan, M. Clodi, R. Prager, G. PaciniInverse relation between amylin and glucagon secretion in healthy and diabetic subjects, Europ. J. of Clin. Invest. 2003;33:316-322 [203 KB]

41) Koller MD, Templ E, Riedl M, M. Clodi, Wagner O, Smolen JS, Luger A.Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus.Ann Rheum Dis. 2004 Dec;63(12):1677-80. Epub 2004 Apr 13. [67 KB]

42) Maier C, Riedl M, M. Clodi, Bieglmayer C, Mlynarik V, Trattnig S, Luger A.Dynamic contrast-enhanced MR imaging of the stimulated pituitary gland.Neuroimage. 2004 May;22(1):347-52. [261 KB]

43) Biesenbach G, Auinger M, M. Clodi, Prischl F, Kramar R; Diabetic Nephropathy Study Group of the Austrian Society of Nephrology. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria. Nephrol Dial Transplant. 2005 Mar;20(3):559-65. [97 KB]

44) Ch. Bieglmayer, M. Clodi, S. KudlacekBiomarker in der Osteologie: Aktueller StandJournal für Mineralstoffwechsel 2006, S 12-16 [395 KB]

45) GM. Wieselthaler, M. Riedl, H. Schima, O. Wagner, W. Waldhäusl, E. Wolner, A. Luger, M. Clodi.Endocrine Function is not impaired in Patients With a Continuous MicroMed-DeBakey Axial Flow PumpJ Card Thor Surg 2007 Jan;133(1):2-6 [117 KB]

46) M. Clodi, G. Locker, K. Lenz: Therapievorenthalt und Therapiereduktion bei invasiven Maßnahmen und künstlicher Ernährung bei schwerstkranken Patienten.Imago hominis, Band 13 – Heft 4 – 2006 [20 KB]

47) C. Maier, M. Riedl, G. Vila, P. Nowotny, M. Wolzt, M. Clodi, B. Ludvik, A.LugerCholinergic regulation of ghrelin and peptide YY release may be impaired in obesity.Diabetes. 2008 Sep;57(9):2332-40. Epub 2008 Jun 20 [286 KB]

48) G. Vila, C. Maier, M. Riedl, P. Nowotny, B. Ludvik, A. Luger, M. ClodiBacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humansJ Clin Endocrinol Metab. 2007 Oct;92(10):3930-4 [175 KB]

49) M. Clodi, M. Resl, D. Stelzeneder, G. Pacini, A. Tura, D. Mörtl, J.Struck, N.G. Morgentahler, A.Bergmann , M. Riedl, M. Stadler, A. Luger, R. Pacher, M. HülsmannInteractions of glucose metabolism and chronic heart failureExp Clin Endocrinol Diabetes. 2008 Sep 30] [240 KB]